As the leader in syndromic testing,
bioMérieux presents its latest revolutionary offer
in Point-of-Care testing with BIOFIRE® SPOTFIRE®,
a new solution designed with clinicians and their patients in mind.
SYNDROMIC TESTING
FOR POINT-OF-CARE
Due to the similarity of infectious diseases caused by multiple pathogens, diagnosis based on clinical symptoms alone is difficult during a patient appointment.
Rapid and comprehensive onsite results may reduce the need for follow-up appointments, swabbing, and testing. Syndromic testing from BIOFIRE® SPOTFIRE® can help inform timely treatment decisions and may reduce the use of unnecessary antibiotics.
BIOFIRE® SPOTFIRE® SYSTEM
bioMérieux's latest innovation in molecular infectious disease diagnostics,
designed for Point-of-Care testing.
Small and Modular
Minimal benchtop space required and vertically scale up for a customizable throughput
Fully automated
Sample to Result system with bi-directional connectivity (POCT01-A2) for effortless data transfer and seamless reporting
Boosted flexibility
Modules random access to run up to 4 tests at the same time
Easy to use
Intuitive system interface and streamlined workflow allowing usage by healthcare professionals, at any time, in healthcare settings
Product availability varies by country. Consult your bioMérieux representative.
BIOFIRE® SPOTFIRE®
RESPIRATORY (R) PANEL
1 PCR Test. 15 Targets. ~15 Minutes.
BIOFIRE® SPOTFIRE® Respiratory Panel is an expanded syndromic respiratory test developed for Point-of-Care testing.
Respiratory tract infections are a significant cause of morbidity and mortality, and they exact a huge economic cost across the world.
Testing for more than Flu, RSV, and SARS-CoV-2 with one test provides healthcare professionals with the full picture and may timely impact patient therapy and management decisions.
For more info about the panel menu
Product availability varies by country. Consult your bioMérieux representative.
